Home/Filings/4/0001127602-22-016395
4//SEC Filing

LEVIN ALAN G 4

Accession 0001127602-22-016395

CIK 0000882796other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:37 PM ET

Size

4.5 KB

Accession

0001127602-22-016395

Insider Transaction Report

Form 4
Period: 2022-05-31
LEVIN ALAN G
Director
Transactions
  • Award

    Common Stock

    2022-05-31$9.31/sh+1,138$10,5953,197 total
Footnotes (1)
  • [F1]Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $11,250, prorated to $10,597.83 based on the increase in the annual retainer fee effective April 18, 2022.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001174452

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:37 PM ET
Size
4.5 KB